diabetes

Showing 15 posts of 391 posts found.

Victoza pill trial begins

January 19, 2010
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Victoza, diabetes, type II

A promising new diabetes treatment which can be taken as a pill instead of as an injection has just begun …

Virtual 3D community Second Life

Digital Pharma: Virtual diabetes patient community launched on Second Life

January 13, 2010
Medical Communications Diabetes UK, Second Life, diabetes, digital pharma

Patient group Diabetes UK has, quite literally, set up shop on Second Life, establishing its own office in the online …

BIC_03 2

Boehringer prepares for diabetes launch

December 3, 2009
Medical Communications Boehringer, DPP-4, diabetes

Boehringer Ingelheim has hired the London arm of international PR agency Weber Shandwick to handle the UK launch of its …

AZ-BMS launch Onglyza in Europe

October 19, 2009
Sales and Marketing AZ, BMS, DPP-4, Onglyza, diabetes

 Bristol-Myers Squibb and AstraZeneca’s long-awaited type II diabetes drug Onglyza has been launched in the UK, its first European market.Designed …

US approval for Onglyza

August 6, 2009
Research and Development, Sales and Marketing AZ, BMA, diabetes

Adult type II diabetes treatment Onglyza has been approved by the US Food and Drug Administration. Co-marketed by AstraZeneca and …

Victoza launched in UK

July 9, 2009
Sales and Marketing Victoza, diabetes

Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …

Sanofi moves to quell Lantus safety concerns

July 7, 2009
Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes

Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …

BMS and AZ launch diabetes patient survey

June 19, 2009
Medical Communications, Sales and Marketing diabetes

Bristol-Myers Squibb and AstraZeneca have joined forces with Diabetes UK to launch a national patient survey on the effects of …

Genentechlr

Genentech forms type I diabetes collaboration

June 11, 2009
Research and Development Roche, diabetes

 The deal gives the Roche-owned biotech development and marketing rights to Bayhill’s molecule BHT-3021, which is currently in phase I/II …

Takeda delays diabetes drug in Europe

June 4, 2009
Research and Development, Sales and Marketing Takeda, diabetes

Takeda is to delay seeking European approval of its key drug candidate alogliptin, and instead take another two years to …

Novo Nordisk plans summer launches for new diabetes drug

May 7, 2009
Research and Development, Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk is preparing Victoza for a summer launch into its first European markets, including the UK, after it was …

Mannkind picks up Pfizer’s Exubera facility

March 16, 2009
Manufacturing and Production Mannkind, diabetes

The demise of Pfizer's inhaled diabetes treatment Exubera cast a pall over the prospects for inhaled insulin therapy, but has …

GSK’s diabetes candidate enters phase III

February 19, 2009
Research and Development GSK, diabetes

A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …

The Gateway to Local Adoption Series

Latest content